Disease: Diffuse Intrinsic Pontine Glioma
- A blocking monoclonal antibody reveals dimerization of intracellular domains of ALK2 associated with genetic disorders
- A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma
- A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4
- A multimodal imaging-based classification for pediatric diffuse intrinsic pontine gliomas
- A Phase 1 Study of Intravenous EGFR-ErbituxEDVsMIT in Children with Solid or CNS Tumours Expressing Epidermal Growth Factor Receptor
- A Phase I Trial of Panobinostat in Children with Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium (PBTC-047)
- ACTION: A randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma
- Adaptive rewiring of purine metabolism promotes treatment resistance in H3K27M-mutant diffuse midline glioma
- Addendum: Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report
- Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium
- Alternative Lengthening of Telomeres in Pediatric High-Grade Glioma and Therapeutic Implications
- Anti-tumor efficacy of anti-GD2 CAR NK-92 cells in diffuse intrinsic pontine gliomas
- Antisense oligonucleotide therapy for H3.3K27M diffuse midline glioma
- B7-H3 in Brain Malignancies: Immunology and Immunotherapy
- Bench-to-bedside investigations of H3 K27-altered diffuse midline glioma: drug targets and potential pharmacotherapies
- Bevacizumab for the early clinical progression of diffuse intrinsic pontine glioma
- BMP signaling in cancer stemness and differentiation
- Bone Morphogenic Proteins in Pediatric Diffuse Midline Gliomas: How to Make New Out of Old?
- Boswellic acid formulations are not suitable for treatment of pediatric high-grade glioma due to tumor promoting potential
- Bridging the age gap: a review of molecularly informed treatments for glioma in adolescents and young adults
- CAR T cell therapies for diffuse midline glioma
- CAR T-cell therapy: a potential treatment strategy for pediatric midline gliomas
- Chaetocin-mediated SUV39H1 inhibition targets stemness and oncogenic networks of diffuse midline gliomas and synergizes with ONC201
- Classification of Brainstem Gliomas Based on Tumor Microenvironment Status
- Clinical characteristics and prognostic factors of surgical treatment in children with brainstem tumor
- Clinical experience with immunotherapy in patients with diffuse intrinsic pontine glioma
- Detection of cell-free histones in the cerebrospinal fluid of pediatric central nervous system malignancies by imaging flow cytometry
- Diffuse Intrinsic Pontine Glioma
- Diffuse intrinsic pontine glioma (DIPG): A review of current and emerging treatment strategies
- Diffuse Midline Gliomas: Challenges and New Strategies in a Changing Clinical Landscape
- Dimethyl alpha-ketoglutarate inhibits proliferation in diffuse intrinsic pontine glioma by reprogramming epigenetic and transcriptional networks
- DIPG-like MYB-altered diffuse astrocytoma with durable response to intensive chemotherapy
- Discovery of Conformationally Constrained ALK2 Inhibitors
- DNA methylation landscapes in DIPG reveal methylome variability that can be modified pharmacologically
- DNA Methylation Profiles Are Stable in H3 K27M-Mutant Diffuse Midline Glioma Neurosphere Cell Lines
- Effects of tumour heterogeneous properties on modelling the transport of radiative particles
- Emerging strategies to fabricate polymeric nanocarriers for enhanced drug delivery across blood-brain barrier: An overview
- Engineered extracellular vesicles (EVs): Promising diagnostic/therapeutic tools for pediatric high-grade glioma
- Epidemiology, Diagnostic Strategies, and Therapeutic Advances in Diffuse Midline Glioma
- Epigenetic and Metabolic Changes in Diffuse Intrinsic Pontine Glioma
- Erratum: Neurological symptom improvement after re-irradiation in patients with diffuse intrinsic pontine glioma: A retrospective analysis of the SIOP-E-HGG/DIPG project
- Evaluating drug distribution in children and young adults with diffuse midline glioma of the pons (DIPG) treated with convection-enhanced drug delivery
- Expression of Interleukin-13 Receptor Alpha 2 in Brainstem Gliomas
- Extra-neural metastases in pediatric diffuse midline gliomas, H3 K27-altered: presentation of two cases and literature review
- Fifty years of DIPG: looking at the future with hope
- Fimepinostat Impairs NF-kappaB and PI3K/AKT Signaling and Enhances Gemcitabine Efficacy in H3.3K27M-Diffuse Intrinsic Pontine Glioma
- Fimepinostat Impairs NF-κB and PI3K/AKT Signaling and Enhances Gemcitabine Efficacy in H3.3K27M-Diffuse Intrinsic Pontine Glioma
- Fimepinostat impairs NF-κB and PI3K/AKT signaling and enhances gemcitabine efficacy in H3K27M-mutated diffuse intrinsic pontine glioma
- First-in-human sonodynamic therapy with ALA for pediatric diffuse intrinsic pontine glioma: a phase 1/2 study using low-intensity focused ultrasound : Technical communication
- From Pediatric to Adult Brain Cancer: Exploring Histone H3 Mutations in Australian Brain Cancer Patients
- Glioma synapses recruit mechanisms of adaptive plasticity
- H2A.Z histone variants facilitate HDACi-dependent removal of H3.3K27M mutant protein in pediatric high-grade glioma cells
- H3 K27M-altered Glioma and Diffuse Intrinsic Pontine Glioma: Semi-systematic Review of Treatment Landscape and Future Directions
- Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment
- Helical tomotherapy craniospinal irradiation in primary brain tumours: Toxicities and outcomes in a peadiatric and adult population
- HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma
- Hypofractionated re-irradiation for diffuse intrinsic pontine glioma
- Imaging biomarkers and radiomics in pediatric oncology: a view from the PRIMAGE (PRedictive In silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers) project
- Implementing data on targeted therapy from the INFORM registry platform for children with relapsed cancer in Sweden
- In vitro vascular differentiation system efficiently produces natural killer cells for cancer immunotherapies
- Indoximod-based chemo-immunotherapy for pediatric brain tumors: a first-in-children phase 1 trial
- Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial
- Influence of socioeconomic status on clinical outcomes of diffuse midline glioma and diffuse intrinsic pontine glioma
- Just a spoonful of metformin helps the medicine go down
- Medullary brainstem gliomas in an adult: A rare case report and challenging tumor
- Microtubule-Targeting Combined with HDAC Inhibition Is a Novel Therapeutic Strategy for Diffuse Intrinsic Pontine Gliomas
- MRI-Guided Focused Ultrasound Blood-Brain Barrier Opening Increases Drug Delivery and Efficacy in a Diffuse Midline Glioma Mouse Model
- MRI-guided focused ultrasound blood-brain barrier opening increases drug delivery and efficacy in a diffuse midline glioma mouse model
- Nimotuzumab-vinorelbine combination therapy versus other regimens in the treatment of pediatric diffuse intrinsic pontine glioma
- ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma
- ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
- Oncohistones and disrupted development in pediatric-type diffuse high-grade glioma
- Oncolytic virotherapy for the treatment of pediatric brainstem gliomas
- Palliative care for children with central nervous system tumors: results of a Spanish multicenter study
- Pharmacological Targeting of Interferon-Related DNA Damage Resistant Signature (IRDS) and XRCC4-Mediated DNA Repair Pathways ss a Novel Therapeutic Approach to DIPG Radio-Sensitization
- Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047)
- PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma
- PNOC015: Repeated convection enhanced delivery (CED) of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG)
- PNOC015: Repeated convection-enhanced delivery of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma
- Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
- Radiotherapy for Diffuse Intrinsic Pontine Glioma: Insufficient but Indispensable
- Rapid Peroxide Removal Limits the Radiosensitization of Diffuse Intrinsic Pontine Glioma (DIPG) Cells by Pharmacologic Ascorbate
- Re-Irradiation for Diffuse Intrinsic Pontine Glioma with 3 Gy per Fraction
- Re-irradiation for recurrent/progressive pediatric brain tumors: from radiobiology to clinical outcomes
- Re-irradiation in Paediatric Tumours of the Central Nervous System: National Guidelines from the Swedish Workgroup of Paediatric Radiotherapy
- Review of imaging recommendations from Response Assessment in Pediatric Neuro-Oncology (RAPNO)
- Role of neuronavigation in the surgical management of brainstem gliomas
- Sequencing checkpoint inhibitor therapy in renal cell carcinoma
- Spontaneous Regression of Glioma-Mimicking Brainstem Lesion in a Child: A Case Report
- Survival and neurological outcomes after stereotactic biopsy of diffuse intrinsic pontine glioma: a systematic review
- Targeting diffuse midline gliomas: The promise of focused ultrasound-mediated blood-brain barrier opening
- Targeting DNA Repair and Survival Signaling in Diffuse Intrinsic Pontine Gliomas to Prevent Tumor Recurrence
- Targeting SWI/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomas
- Teaching Video NeuroImage: Oculomotor Apraxia as the Only Presentation of Diffuse Intrinsic Pontine Glioma
- The Role of Reirradiation in Childhood Progressive Diffuse Intrinsic Pontine Glioma (DIPG): An Ongoing Challenge beyond Radiobiology
- Theranostic Uses of the Heme Pathway in Neuro-Oncology: Protoporphyrin IX (PpIX) and Its Journey from Photodynamic Therapy (PDT) through Photodynamic Diagnosis (PDD) to Sonodynamic Therapy (SDT)
- Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma
- TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory
- TIM-3 blockade: immune and targeted therapy in DIPG
- Very Long-term Survivorship in Pediatric DIPG: Case Report and Review of the Literature